SYNAPTOGENIX
Synaptogenix is a clinical-stage biotech company leveraging Bryostatin-1 and its analogs to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders. The company has targeted Bryostatin-1 due to its high potential and multi-modal efficacy: through protein kinase C (PKCĻµ) activation, Bryostatin-1 stimulates synaptic growth factors, amyloid-Ī² degrading enzymes, as well as prevents Tau transformation into neurofibrillary tangles.
SYNAPTOGENIX
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.synaptogen.com
Total Employee:
11+
Status:
Active
Contact:
973-242-0005
Total Funding:
26.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.synaptogen.com Semrush global rank: 2.71 M Semrush visits lastest month: 6.06 K
- Host name: dp-0f36a8c345.dreamhostps.com
- IP address: 208.113.252.6
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
